Key Takeaways
- HSBC cut Nike’s rating from “Buy” to “Hold,” establishing a $48 price objective amid expectations of prolonged recovery and falling revenues
- Shares of NKE began trading at $42.59, hovering close to the 52-week bottom of $42.36, a sharp decline from the $80.17 yearly peak
- The athletic footwear giant confronts approximately $1.5 billion in additional yearly expenses due to American import duties
- HSBC projects the worldwide athletic apparel sector will expand roughly 3.9% through 2026, though Nike appears poised to surrender share to Adidas, On, and Arc’teryx
- A pair of Nike board members acquired shares during early April, including Robert Holmes Swan who secured 11,781 shares valued at approximately $500,000
The athletic footwear titan’s shares have plummeted to price levels unseen for more than ten years, prompting investment banks to reassess their positions.
On April 13, HSBC revised its stance on NKE, moving from “Buy” to “Hold” while establishing a $48 valuation target. This projection suggests roughly 12.7% potential appreciation from current trading levels — hardly an enthusiastic outlook.
The financial institution’s assessment was candid. Nike’s transformation effort is progressing more slowly than anticipated. Top-line figures are expected to contract in upcoming quarters, while earnings projections have been revised downward. Meanwhile, expense pressures continue mounting.
Shares commenced Monday’s session at $42.59, marginally above the yearly floor of $42.36. The equity has surrendered approximately half its value from the 52-week peak of $80.17. Current market capitalization hovers around $63 billion.
HSBC isn’t alone in moderating expectations. Citigroup reduced its price objective from $65 down to $53. Piper Sandler adjusted downward from $60 to $50. Evercore moved from $69 to $57, while maintaining an “outperform” stance. Guggenheim shifted from $77 to $74 but preserved its “buy” recommendation. The collective view among 36 Wall Street analysts now registers as “Hold,” with a mean target of $62.34.
Import Duties Create Headwinds
Among the most significant challenges weighing on shares is tariff vulnerability. HSBC calculates Nike confronts $1.5 billion in extra annual expenses stemming from American import levies. Adidas anticipates a €200 million impact in 2026. Given Nike’s extensive offshore manufacturing footprint, near-term mitigation options appear limited.
HSBC’s comprehensive sector analysis highlighted increased promotional activity throughout Western economies as Nike addresses its inventory surplus. The Chinese market presents compounded difficulties — softening economic fundamentals coupled with intensifying domestic competition are eroding the company’s positioning.
The global athletic wear industry is anticipated to expand approximately 3.9% in 2026, with the Asia-Pacific region driving growth. However, HSBC forecasts Nike will cede territory to competitors including Adidas and emerging brands On and Arc’teryx.
Nike’s third-quarter performance, disclosed March 31, narrowly exceeded projections. Earnings per share registered $0.35 compared to the $0.29 Street estimate. Total revenue reached $11.28 billion, marginally surpassing the $11.23 billion forecast. Year-over-year sales growth measured just 0.1%. For comparison, the corresponding period previously generated $0.54 EPS.
Board Members Accumulating Shares
Not all stakeholders are retreating. A pair of Nike board members purchased equity during early April. Robert Holmes Swan acquired 11,781 shares at $42.44 per unit, representing an investment totaling approximately $500,000. This transaction expanded his ownership stake by 27.2%. Board member John W. Rogers Jr. secured 4,000 shares at $43.34, a $173,360 purchase that increased his holdings by 10.8%.
Institutional investors control 64.25% of outstanding shares. Brighton Jones LLC expanded its allocation by 388.5% during the fourth quarter of last year, adding more than 160,000 units.
Wall Street analysts currently forecast Nike will deliver full-year EPS of $2.05 for the ongoing fiscal period. The price-to-earnings multiple stands at 28.21. The 50-day simple moving average registers at $56.46 while the 200-day average sits at $62.07 — both substantially above present trading levels.
